CSL is an Australian biotech company with a market cap of more than A$130 billion dollars, making it the country’s third biggest listed company, behind BHP and Commonwealth Bank.

In this week’s podcast, Rebecca Jones asks Bloomberg News reporter Amy Bainbridge and senior editor Jason Gale how CSL became a market favorite and about the headwinds it’s facing in the post-pandemic era.

CSL is an Australian biotech company with a market cap of more than A$130 billion dollars, making it the country’s third biggest listed company, behind BHP and Commonwealth Bank. In this week’s podcast, Rebecca Jones asks Bloomberg News reporter Amy Bainbridge and senior editor Jason Gale how CSL became a market favorite and about the headwinds it’s facing in the post-pandemic era.

Each week, Rebecca Jones and Bloomberg's team of reporters lift the lid on the biggest stories shaping Australia's place in global business. 

Each week, Rebecca Jones and Bloomberg's team of reporters lift the lid on the biggest stories shaping Australia's place in global business.

Each week, Rebecca Jones and Bloomberg's team of reporters lift the lid on the biggest stories shaping Australia's place in global business.

The Bloomberg Australia Podcast

Each week, Rebecca Jones and Bloomberg's team of reporters lift the lid on the biggest stories shaping Australia's place in global business.

Inside CSL’s Empire of Blood and Iron

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/2fb106bc-ef22-4289-86e2-b236000cf5b5/transcript

Advertisement